ImmunityBio Inc. Common Stock vs iShares US Power Infrastructure ETF — how do they compare? ImmunityBio Inc. Common Stock trades at $9.98 (market cap $10.51B), while iShares US Power Infrastructure ETF trades at $25.27 (market cap $446.54M). The key difference: ImmunityBio Inc. Common Stock is far larger — about 23.5× iShares US Power Infrastructure ETF's market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, iShares US Power Infrastructure ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and iShares US Power Infrastructure ETF for 13 Days on average.
| IBRX | POWR | |
|---|---|---|
Market Cap | $10.51B | $446.54M |
Volume | 10,445,785 | 160,852 |
Sector | Health | Sector/Thematic |
52-Week High | $11.55 | $28.22 |
52-Week Low | $1.98 | $23.20 |
Typical Hold Time | 0 Days | 13 Days |
Enterprise Value | $10.97B | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →iShares U.S. Power Infrastructure ETF seeks exposure to U.S. companies involved in power infrastructure. Its holdings may include electric utilities, transmission and distribution businesses, and electrical equipment providers.
Read more on POWR →